Skip to main content

Table 1 Clinical success and mortality [19]

From: Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis

Drug

Clinical success

Mortality

Anidulafungin

77.5 %

20.8 %

Fluconazole

63.0 %

28.4 %

Caspofungin

76.1 %

33.8 %

Micafungin

76.0 %

39.2 %

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us